
Biocura Life Sciences Private Limited
About Biocura Life Sciences Private Limited
Data last updated:
Biocura Life Sciences Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 April 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24230KA2007PTC042473. Its GSTIN is 29AAFCB6495G1Z9 (Karnataka).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹25 Lakh. It is led by directors Satish Kamalaksha Rao (Managing Director) and Mamatha Satish Rao.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.7 Cr, a decline of 8% compared to the previous year. For the same year it recorded a net profit of ₹14.28 Lakh (net margin 5.3%) and EBITDA of ₹18.63 Lakh (EBITDA margin 6.9%). Revenue has declined at a compounded annual rate (CAGR) of 4% over three years and 4% over five years.
As per MCA filings, the company has open charges of ₹1.36 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Biocura Life Sciences Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address is in the company report.
- Email
- Registered AddressNo. 76 1st Floor 1st Main 5th Phae Shivnagar 60 Ft Road Mahaganapathi Naga, R, Bangalore, Karnataka, India – 560044
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Biocura Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Biocura Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Biocura Life Sciences Private Limited, buy the company report.
Financials of Biocura Life Sciences Private Limited
FY 2025 filings availableBiocura Life Sciences Private Limited reported revenue of ₹2.7 Cr (down 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 4% over five years, including a 8% fall in the latest year. EBITDA fell 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹18.63 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹14.28 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.9% | ||||
| Net Profit Margin | 5.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Biocura Life Sciences Private Limited, buy the company report.
Board of directors of Biocura Life Sciences Private Limited
Biocura Life Sciences has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satish Kamalaksha Rao | Managing Director | 12 Apr 2007 | 19 Years 6 Months | Current |
| Mamatha Satish Rao | Director | 12 Apr 2007 | 19 Years 6 Months | Current |
Peer comparison
Biocura Life Sciences Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kalpataru Formulations Private Limited | ₹2.71 Cr (FY 2025) | -4.0% | Ahmedabad, Gujarat, India | |||
| Parasol Laboratories India Private Limited | ₹2.7 Cr (FY 2024) | 11.0% | Chandigarh, India | |||
| Padm Chem Research Private Limited | ₹2.7 Cr (FY 2024) | -14.0% | Bangalore, Karnataka, India | |||
| Biocura Life Sciences Private Limitedthis company | ₹2.7 Cr (FY 2025) | ₹14.28 Lakh | 5.3% | -8.0% | Bangalore, Karnataka, India | |
| Chilika Pharmaceutical Private Limited | ₹2.69 Cr (FY 2025) | 32.0% | Deoghar, Jharkhand, India |
To see the full peer comparison of Biocura Life Sciences Private Limited, buy the company report.
Shareholding
The shareholding of Biocura Life Sciences Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Biocura Life Sciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Oct 2025 | 101170351 | Indian Bank | ₹36 Lakh | Open | |
| 06 Feb 2014 | 10478999 | Icici Bank Limited | ₹1 Cr | Open |
To see the full charge records of Biocura Life Sciences Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Biocura Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Biocura Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Biocura Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAFCB6495G1Z9 | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Biocura Life Sciences Private Limited, buy the company report.
Recent activity
Biocura Life Sciences Private Limited has 3 board changes on record since 2007: 2 appointments and 1 cessation. The latest: Kusuma Rao ceased to be Director on 29 Mar 2015.
Frequently asked questions
Biocura Life Sciences is an active private limited company based in Bangalore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 April 2007 (19+ years old) and is registered under CIN U24230KA2007PTC042473.
Biocura Life Sciences has 2 current directors:
- Satish Kamalaksha Rao - Managing Director
- Mamatha Satish Rao - Director
The latest financial statements of Biocura Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Biocura Life Sciences is 29AAFCB6495G1Z9, registered in Karnataka.
The CIN (Corporate Identification Number) of Biocura Life Sciences is U24230KA2007PTC042473. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Biocura Life Sciences was incorporated on 12 April 2007, making it 19+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Biocura Life Sciences by revenue are Kalpataru Formulations Private Limited, Parasol Laboratories India Private Limited, Padm Chem Research Private Limited, Chilika Pharmaceutical Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Kusuma Rao ceased to be Director on 29 Mar 2015. Mamatha Satish Rao was appointed as Director on 12 Apr 2007. Satish Kamalaksha Rao was appointed as Managing Director on 12 Apr 2007.
The registered office of Biocura Life Sciences is at No. 76 1st Floor 1st Main 5th Phae Shivnagar 60 Ft Road Mahaganapathi Naga, R, Bangalore, Karnataka, India – 560044.
Biocura Life Sciences operates in the pharma industry, in the drug formulation and development segment.
Biocura Life Sciences has open charges of ₹1.36 Cr and no satisfied charges on record as per latest MCA filings.

